A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 4 November 2023) has been published and includes articles on: Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir E-cigarette use or vaping: reminder
Read moreThe Chancellor of the Exchequer, Jeremy Hunt, gave his Autumn Statement to Parliament yesterday (22nd), setting out future Government spending plans. One of the key announcements in the Statement was that the National Minimum Wage (NMW) is set to increase from £10.42 to £11.44. Minsters said this represented a rise of more than £1,800 a
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (17/11/2023) announced the following initial list of price concessions for November 2023. Drug Pack size Price concession Acamprosate 333mg gastro-resistant tablets 168 £22.76 Aciclovir 800mg tablets 35 £3.60
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 250mg/5ml oral suspension are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP054 Clarithromycin 250mg/5ml oral suspension at 23.59pm on Friday 17 November 2023. After this date, any prescriptions for Clarithromycin 250mg/5ml oral suspension must be
Read moreIn our latest blog, Steve Brine MP, who chairs the Parliamentary Health and Social Care Committee, talks about the Committee’s ongoing inquiry into pharmacy. This will be a critical inquiry for the sector, and Community Pharmacy England will continue to support the MPs on the Committee in any way that we can. We are also
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Rasagiline 1mg tablets. MSN/2023/107 Tier 3 – high impact Date of issue 16th November 2023 Rasagiline 1mg tablets are in limited supply until mid-December 2023. Unlicensed supplies of rasagiline 1mg tablets may be sourced, lead times vary. Selegiline (Eldepryl®) 5mg and
Read moreCommunity Pharmacy England has reached agreement with Government and the NHS on the launch of a new national Pharmacy First service as well as other changes to pharmacy funding and services. Our Committee unanimously agreed to accept the deal which sets out how the £645 million investment pledged within the Delivery plan for recovering access
Read moreNHS England has announced that NHS approved IT systems for recording NMS consultations and sharing data with the NHSBSA are due to be ready from 1st December 2023. This development follows negotiations with NHS England and the Department of Health and Social Care where it has previously been agreed that IT support for CPCF clinical
Read moreNHS approved IT systems for recording SCS and DMS consultations and sharing data with the NHSBSA are due to be ready in the first quarter of 2024. This development follows negotiations with NHS England and the Department of Health and Social Care where it has previously been agreed that IT support for CPCF clinical services
Read moreIn a new feature for the NHS App, patients will be able to view their EPS prescribed items. The app will show the items prescribed, the prescription type (repeat or one-off) and who the prescriber is. Piloting NHS England’s Transformation Directorate has been piloting this new feature with four GP practices in a West Yorkshire
Read more
